Outpatient Vyxeos Induction without Planned Admission for Select Patients with Secondary Acute Myeloid Leukemia (sAML) Is Safe and Yields Healthcare Resource Savings

Authors

• M Kasner

Publication/Presentation Date

11-2020

Volume

136

Issue

1

First Page

2

Last Page

2

Published In/Presented At

https://doi.org/10.1182/blood-2020-140055

Department(s)

Hematology-Medical Oncology Division

Document Type

Article